In HNSCC, high levels of TAMs in the tumor micro-environment are correlated with poor prognosis, because of the CTLA-4-mediated immunosuppression and the expression of immunosuppressive cytokines and PD-L1 [77,90]. The gene discussed is CTLA4; the disease is head and neck squamous cell carcinoma.